An update from Palm Springs – Huntington’s disease Therapeutics Conference 2020
CHDI’s Huntington’s disease Therapeutics Conference 2020 has taken place and today we bring you the major research updates from the conference.
Below is a video from CHDI, hosted by Charles Sabine. In the video, Charles discusses how these are hopeful times in Huntington’s drug development and gives updates on HTT-lowering therapeutics, including an update on the Roche ASO Phase 3 trial, brand new therapeutic approaches that have come out of the GWAS modifier gene studies and a just-published study of premanifest Huntington’s in young adults.
Watch the update video below.
CHDI’s Huntington’s disease Therapeutics Conference 2020 has taken place and today we bring you the major research updates from the conference.
Below is a video from CHDI, hosted by Charles Sabine. In the video, Charles discusses how these are hopeful times in Huntington’s drug development and gives updates on HTT-lowering therapeutics, including an update on the Roche ASO Phase 3 trial, brand new therapeutic approaches that have come out of the GWAS modifier gene studies and a just-published study of premanifest Huntington’s in young adults.
Watch the update video below.